Skip to main content
Log in

Simultaneous Determination of Safingol and d-erythro-Sphinganine in Human Plasma by LC with Fluorescence Detection

  • Full Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

l-threo-Sphinganine (safingol) is a putative synthetic sphingosine kinase inhibitor currently being tested in clinical trials as an anticancer agent. To enable defining the pharmacokinetic properties of safingol in humans, we developed a sensitive analytical method to simultaneously quantitate safingol and its naturally-occurring diastereomer, d-erythro-sphinganine in human plasma. Of the two different fluorogenic derivatization agents (NDA and OPA) and several pH conditions compared for the derivatization, we found that NDA derivatization achieved more than 20 times greater sensitivity compared with OPA derivatization, and pH 9.0 showed the highest sensitivity for both compounds. An analytical method for liquid chromatography (LC) with a fluorescence detector (FLD) was developed and validated with calibration curve ranges of 20–1,000 ng mL−1 for safingol and d-erythro-sphinganine. Our LC-FLD method using NDA-derivatization enabled simultaneous quantification of safingol and its naturally-occurring diastereomer, d-erythro-sphinganine with satisfactory sensitivity in human plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Banno Y, Kato M, Hara A, Nozawa Y (1998) Biochem J 335(Pt 2):301–304

    CAS  Google Scholar 

  2. Maurer BJ, Melton L, Billups C, Cabot MC, Reynolds CP (2000) J Natl Cancer Inst 92:1897–1909. doi:10.1093/jnci/92.23.1897

    Article  CAS  Google Scholar 

  3. Reynolds CP, Maurer BJ, Kolesnick RN (2004) Cancer Lett 206:169–180. doi:10.1016/j.canlet.2003.08.034

    Article  CAS  Google Scholar 

  4. Sachs CW, Safa AR, Harrison SD, Fine RL (1995) J Biol Chem 270:26639–26648

    Article  CAS  Google Scholar 

  5. Liscovitch M, Ravid D (2007) Cancer Lett 245:350–352. doi:10.1016/j.canlet.2006.01.013

    Article  CAS  Google Scholar 

  6. Schwartz GK, Ward D, Saltz L, Casper ES, Spiess T, Mullen E, Woodworth J, Venuti R, Zervos P, Storniolo AM, Kelsen DP (1997) Clin Cancer Res 3:537–543

    CAS  Google Scholar 

  7. Carvajal RD, Merrill AH Jr, Dials H, Barbi A, Schwartz GK (2006) J Clin Oncol 24:13044. http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/13044

    Google Scholar 

  8. Rajewski RA, Kosednar DG, Matches TA, Wong OS, Burchett K, Thakker K (1995) J Pharm Biomed Anal 13:247–253

    Article  CAS  Google Scholar 

  9. Gorska M, Dobrzyn A, Baranowski M (2005) Med Sci Monit 11:CR35–CR38

    CAS  Google Scholar 

  10. Cho YH, Yoo HS, Min JK, Lee EY, Hong SP, Chung YB, Lee YM (2002) J Chromatogr A 977:69–76

    Article  CAS  Google Scholar 

  11. He X, Dagan A, Gatt S, Schuchman EH (2005) Anal Biochem 340:113–122. doi:10.1016/j.ab.2005.01.058

    Article  CAS  Google Scholar 

  12. Merrill AH Jr, Wang E, Mullins RE, Jamison WC, Nimkar S, Liotta DC (1988) Anal Biochem 171:373–381

    Article  CAS  Google Scholar 

  13. Ribar S, Mesaric M, Bauman M (2001) J Chromatogr B Biomed Sci Appl 754:511–519

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Min H. Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JS., Singh, H., Maurer, B.J. et al. Simultaneous Determination of Safingol and d-erythro-Sphinganine in Human Plasma by LC with Fluorescence Detection. Chroma 71, 1087–1091 (2010). https://doi.org/10.1365/s10337-010-1588-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-010-1588-8

Keywords

Navigation